About Aqemia
Aqemia is a company based in Paris (France) founded in 2019 by Maximilien Levesque.. Aqemia has raised $102.82 million across 5 funding rounds from investors including Eurazeo, Bpifrance and Wendel. Aqemia offers products and services including AI Drug Discovery Platform and Quantum Physics Algorithms. Aqemia operates in a competitive market with competitors including NTxBio, Nimble Therapeutics, Applied BioMath, Enveda and IMIDomics, among others.
- Headquarter Paris, France
- Founders Maximilien Levesque
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$102.82 M (USD)
in 5 rounds
-
Latest Funding Round
$7.4 M (USD), Grant
Apr 01, 2025
-
Investors
Eurazeo
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aqemia
Aqemia offers a comprehensive portfolio of products and services, including AI Drug Discovery Platform and Quantum Physics Algorithms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses AI and quantum physics to generate drug candidates rapidly.
Algorithms that produce data for early-stage drug discovery projects.
Unlock access to complete
Funding Insights of Aqemia
Aqemia has successfully raised a total of $102.82M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $7.4 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $7.4M
-
First Round
First Round
(17 Oct 2019)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Grant - Aqemia | Valuation |
investors |
|
| Dec, 2024 | Amount | Series A - Aqemia | Valuation | Cathay Innovation | |
| Jan, 2024 | Amount | Series A - Aqemia | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aqemia
Aqemia has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Eurazeo, Bpifrance and Wendel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in technology startups through a global ecosystem.
|
Founded Year | Domain | Location | |
|
Private equity and funds of funds focused on industrial, media, energy, healthcare, biotechnology, and multiple sectors
|
Founded Year | Domain | Location | |
|
Private equity and debt investments are managed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aqemia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aqemia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aqemia Comparisons
Competitors of Aqemia
Aqemia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NTxBio, Nimble Therapeutics, Applied BioMath, Enveda and IMIDomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| domain | founded_year | HQ Location |
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
|
| domain | founded_year | HQ Location |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| domain | founded_year | HQ Location |
Provider of AI-based platform to decipher the chemistry of nature and develop new medicines
|
|
| domain | founded_year | HQ Location |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aqemia
Frequently Asked Questions about Aqemia
When was Aqemia founded?
Aqemia was founded in 2019.
Where is Aqemia located?
Aqemia is headquartered in Paris, France.
Who is the current CEO of Aqemia?
Maximilien Levesque is the current CEO of Aqemia. They have also founded this company.
Is Aqemia a funded company?
Aqemia is a funded company, having raised a total of $102.82M across 5 funding rounds to date. The company's 1st funding round was a Series A of $32.49M, raised on Oct 17, 2019.
What does Aqemia do?
Aqemia was founded in 2019 in Paris, France, as a provider of AI-driven software combined with quantum physics for therapeutic molecule discovery. Small molecules are screened using AI-based technology to assess physical properties, supporting upstream processing and drug development. Therapeutic targets linked to specific diseases are identified. Operations focus on biotechnology and pharmaceuticals, aiding research in molecular screening and target validation across global collaborations.
Who are the top competitors of Aqemia?
What products or services does Aqemia offer?
Aqemia offers AI Drug Discovery Platform and Quantum Physics Algorithms.
Who are Aqemia's investors?
Aqemia has 6 investors. Key investors include Eurazeo, Bpifrance, Wendel, unknown, and Cathay Innovation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.